C31G, A NEW AGENT FOR ORAL USE .1. ANTIGLYCOLYTIC TESTS

被引：0
|
作者：
CORNER, AM [1 ]
DOLAN, MM [1 ]
MALAMUD, D [1 ]
YANKELL, SL [1 ]
机构：
[1] UNIV PENN,SCH DENT MED,PHILADELPHIA,PA 19104
来源：
JOURNAL OF DENTAL RESEARCH | 1986年 / 65卷
关键词：
D O I：
暂无
中图分类号：
R78 [口腔科学];
学科分类号：
1003 ;
摘要：
引用
收藏
页码：274 / 274
页数：1
相关论文
共 50 条
  • [21] EFFECT OF C31G, AN ANTI-MICROBIAL SURFACTANT, ON HEALING OF INCISED GUINEA-PIG WOUNDS
    MICHAELS, EB
    HAHN, EC
    KENYON, AJ
    AMERICAN JOURNAL OF VETERINARY RESEARCH, 1983, 44 (07) : 1378 - 1381
  • [22] Toxicity, inflammation, and anti-human immunodeficiency virus type 1 activity following exposure to chemical moieties of C31G
    Catalone, BJ
    Miller, SR
    Ferguson, ML
    Malamud, D
    Kish-Catalone, T
    Thakkar, NJ
    Krebs, FC
    Howett, MK
    Wigdahl, B
    BIOMEDICINE & PHARMACOTHERAPY, 2005, 59 (08) : 430 - 437
  • [23] Inactivation of human immunodeficiency virus type 1 by nonoxynol-9, C31G, or an alkyl sulfate, sodium dodecyl sulfate
    Krebs, FC
    Miller, SR
    Malamud, D
    Howett, MK
    Wigdahl, B
    ANTIVIRAL RESEARCH, 1999, 43 (03) : 157 - 173
  • [24] Vaginal and rectal topical microbicide development: Safety and efficacy of 1.0% savvy (C31G) in the pigtailed macaque
    Patton, Dorothy L.
    Sweeney, Yvonne T. Cosgrove
    Balkus, Jennifer E.
    Hillier, Sharon L.
    SEXUALLY TRANSMITTED DISEASES, 2006, 33 (11) : 691 - 695
  • [25] Contraceptive Efficacy, Acceptability, and Safety of C31G and Nonoxynol-9 Spermicidal Gels A Randomized Controlled Trial
    Burke, Anne E.
    Barnhart, Kurt
    Jensen, Jeffrey T.
    Creinin, Mitchell D.
    Walsh, Terri L.
    Wan, Livia S.
    Westhoff, Carolyn
    Thomas, Michael
    Archer, David
    Wu, Hongsheng
    Liu, James
    Schlaff, William
    Carr, Bruce R.
    Blithe, Diana
    OBSTETRICS AND GYNECOLOGY, 2010, 116 (06): : 1265 - 1273
  • [26] Sodium dodecyl sulfate and C31G as microbicidal alternatives to nonoxynol 9: Comparative sensitivity of primary human vaginal keratinocytes
    Krebs, FC
    Miller, SR
    Catalone, BJ
    Welsh, PA
    Malamud, D
    Howett, MK
    Wigdahl, B
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2000, 44 (07) : 1954 - 1960
  • [27] The distribution of a 3.5 ml (1.0%) C31G vaginal gel (Savvy) using Magnetic Resonence Imaging.
    Timbers, K
    Barnhart, KT
    Pretorius, ES
    Marunich, R
    Hummel, A
    Malamud, D
    FERTILITY AND STERILITY, 2003, 80 : S219 - S219
  • [28] SPANISH - ORAL APPROACH .1. TEACHERS MANUAL AND TESTS - MAJOR,F AND MICHALSKI,C
    REYES, EP
    MODERN LANGUAGE JOURNAL, 1967, 51 (01): : 60 - 60
  • [29] Double-blind clinical trial of C31G mouthrinse inhibition of human supragingival dental plaque formation.
    Siegel, MA
    Depaola, LG
    Williams, GC
    Rams, TE
    JOURNAL OF DENTAL RESEARCH, 1997, 76 : 2748 - 2748
  • [30] CONTRIBUTION TO IDENTIFICATION OF ORAL ANTIDIABETIC AGENT TOLBUTAMIDE .1.
    OELSCHLAGER, H
    BLUME, H
    ARZNEIMITTEL-FORSCHUNG/DRUG RESEARCH, 1976, 26 (03): : 303 - 311
12345